肠道菌群及其代谢产物在结直肠癌中的研究进展
作者: |
1李智勇,
1魏云巍
1 哈尔滨医科大学附属第一医院肿瘤、腔镜外科,哈尔滨 150001 |
通讯: |
魏云巍
Email: hydwyw11@hotmail.con |
DOI: | 10.3978/j.issn.2095-6959.2022.10.034 |
基金: | 国家自然科学基金(81970466)。 |
摘要
Research progress of gut microbiota and its metabolites in colorectal cancer
CorrespondingAuthor: WEI Yunwei Email: hydwyw11@hotmail.con
DOI: 10.3978/j.issn.2095-6959.2022.10.034
Foundation: This work was supported by the National Nature Science Foundation of China (81970466).
Abstract
Colorectal cancer (CRC) accounts for about 10% of all new cancer cases globally. However, the etiology and pathogenesis of CRC are not fully understood. The gut microbiota consists of a large number of intestinal microorganisms located near the intestinal epithelium and is involved in host physiological activities such as energy acquisition, metabolism and immune response. Increasing evidence suggests that dysbiosis of gut microbiota can affect the occurrence, development and treatment response of CRC by directly or indirectly altering host physiological processes. Furthermore, the mechanisms by which the gut microbiota affects CRC could lead to new diagnostic and therapeutic approaches, but many remain unknown.